When the medium is the messenger the art of communicating with spirits – Apollo Magazine

On 23 March, Drawing Room in London was set to open Not Without My Ghosts: The Artist as Medium, co-organised with Hayward Gallery Touring. The shows roster includes more than 30 artists active over the last 200 years, from historical heavyweights (William Blake) and forgotten pioneers only now gainting traction (Georgiana Houghton) to Surrealists, occultists and contemporary practitioners. Its intention is to take a long view of arts interest in mediumship, the practice of bridging the divide between the concrete realm of the living and the unseeable world beyond. The exhibition and its planned tour to Blackpool, Sheffield and Swansea has of course been postponed. But, in this period of confusion, it may be apt to turn to the alternate cosmologies of those who seek connection with invisible forces.

Spiritual Crown on Annie Howitt Watts (1867), Georgiana Houghton. Courtesy Vivienne Roberts, London

I try to paint into the unknown, Ann Churchill tells me over the phone. In Octagonal Drawing (1976) one of the three pieces she will provide for the show thick, kaleidoscopic patterns swarm the page, furling to form archetypical symbols: insects, ladders, spiders webs, snakes. Like a number of other artists included in the show, Churchill works automatically, making a mark at the middle of the page and allowing her subconscious to guide her hand outwards. Looking at her paintings, I think of something one of the shows curators, Lars Jakob Bang Larsen, has written in an email: the esoteric wave in art has to do with the ways that social control and political power have become placeless and disembodied under globalisation [] we need images and cognitive maps for this state of affairs. Churchills images read like maps, only their paths favour freedom over any sense of order.

GL 28 (Emotional Soup) (2016), Pia Lindman. Courtesy the artist

Finnish artist Pia Lindman, who will present six small diagrams in pencil and felt tip pen, also works to render the unseeable visible. In GL 28 (Emotional Soup) (2016) a human body has been atomised: its legs a wobbly blue contour, buried under a haze of scribbles; its trunk a rotund shape in orange; its head a levitating, vermillion smudge. Evocative phrases are scrawled across the sheet: Throat Lock, Heart Small, Emotional Soup. The series documents synaesthetic visions witnessed by the artist when healing people. (Her practice fuses various sensory techniques, from the Finnish tradition of Kalevela bone setting to sound and energy healing.) Lindman tells me about her initial scepticism when, during a period of ill health, she first participated in esoteric healing practices (Im a rational being!), but that they cured her. In contemporary culture faith in the spiritual has been usurped by faith in the scientific method and any deviation from this script is deemed sacrilege. But, in Lindmans view, science is just another man-made myth, a narrative framework. And its not that science is wrong, its that this myth is not working.

A Stellar Key to the Summerland (2007), Olivia Plender. Courtesy the artist

Olivia Plender (who will exhibit three comic books and a photograph) finds herself negotiating a position between being a practitioner of spiritualism and a researcher of its often marginalised histories. Because history is written by the powerful, there are a lot of stories that dont get told. Its no coincidence that the show is predominantly made up of work by women artists; historically, mediumship has been a way for women to earn a living, use their intellect and express their politics to carve out space. Spiritualism is also self-organised and anti-authoritarian, anti-elitist and anti- capitalist: low-fi, in Plenders words. You dont need much more than a group of friends to practise a seance. When I asked her why she thought there was such a trend for exhibitions focused on mysticism, she says, Theres not only one way of thinking about space, time, death, relations between humans and animals. The Western post-Enlightenment worldview is not the only worldview.

So, how do the rest of us gain access to unseeable realms? By making maps, interrogating stories, self-organising? Or perhaps theres a simpler way. When I was a kid, I asked my father, How do I become magical?, Churchill tells me. His response: Just by breaking habits.

Drawing Room, London, istemporarily closed to the public due to the Covid-19 outbreak. For more information on Not Without My Ghosts: The Artist as Medium visit theinstitutions website.

Go here to read the rest:

When the medium is the messenger the art of communicating with spirits - Apollo Magazine

Art in times of coronavirus 100 inspiring quotes on World Art Day 2020 – YourStory

UNESCO has proclaimed April 15 as World Art Day, a celebration to promote the development, diffusion, and enjoyment of art. It spans the whole spectrum of visual and performing arts. The date was chosen in honour of Leonardo da Vinci, who was born on April 15, 1452.

Many galleries now have online viewings, and artists are resorting even more to social media for showcasing their offerings. Musicians are streaming their works online, collaborating across the internet, and teaching classes through videoconferencing. Memes and cartoons are cropping up around the world, showcasing the lighter and darker sides of the crisis.

During the extended lockdown, billions of citizens around the world are flocking online to watch movies, listen to music, and read books. Citizens themselves have become amateur artists by sharing videos of their creative works ranging from cooking and dancing to drawings and graphic art.

This compilation of quotes salutes the professional and amateur artists around the world in this time of unprecedented crisis. The quotes reflect gratitude to the artistic and humanistic spirit in each of us, and reinforce the importance of creativity, hope, and compassion in these dark hours.

The quotes in this compilation are drawn from YourStory's articles on art as well as a range of online resources. The photographs are chosen from our weekend PhotoSparks section on art and design. See also our compilations of quotes on the occasion of World Book Day, International Jazz Day, and World Photography Day, as well as Top Quotes of 2019 on Design and Art.

A picture is a poem without words. - Horace

A problem is a chance for you to do your best. - Duke Ellington

A societys competitive advantage will come not from how well its schools teach the multiplication and periodic tables, but from how well they stimulate imagination and creativity. - Albert Einstein

A true artist is not one who is inspired but one who inspires others. - Salvador Dal

A true masterpiece does not tell everything. - Albert Camus

Above all, an artist must never be too easily satisfied with what he has done. - Henri Matisse

All religions, arts and sciences are branches of the same tree. - Albert Einstein

An artist cannot fail; it is a success to be one. - Charles Cooley

An artist discovers his genius the day he dares not to please. - Andre Malraux

An artist is a dreamer consenting to dream of the actual world. - George Santayana

An artist is not paid for his labor but for his vision. - James Whistler

An artist should never be a prisoner of himself, prisoner of style, prisoner of reputation, prisoner of success. - Henri Matisse

An empty canvas is the safest addiction in the world, art is the only drug that won't kill you, instead it'll save your life. - Nikki Rowe

Art doesnt have to be pretty. It has to be meaningful. - Duane Hanson

Art enables us to find ourselves and lose ourselves at the same time. - Thomas Merton

Art evokes the mystery without which the world would not exist. - Ren Magritte

Art has a voice - let it speak. - Rochelle Carr

Art helps us identify with one another and expands our notion of we - from the local to the global. - Olafur Eliasson

Art is a line around your thoughts. - Gustav Klimt

Art is a step in the known toward the unknown. - Kahlil Gibran

Art is meant to disturb, science reassures. - Georges Braque

Art is never finished, only abandoned. - Leonardo da Vinci

Art is not a mirror to hold up to society, but a hammer with which to shape it. - Leon Trotsky

Art is not what you see, but what you make others see. - Edgar Degas

Art is the only serious thing in the world. And the artist is the only person who is never serious. - Oscar Wilde

Art is the only way to run away without leaving home. - Twyla Tharp

Art is the queen of all sciences communicating knowledge to all the generations of the world. - Leonardo da Vinci

As the sun colours flowers, so does art colour life. - John Lubbock

Art should comfort the disturbed and disturb the comfortable. - Banksy

Art washes away from the soul the dust of everyday life. - Pablo Picasso

Art wasnt supposed to look nice; it was supposed to make you feel something. - Rainbow Rowell

Artists are just children who refuse to put down their crayons. - Al Hirschfeld

Artwork is a representation of our devotion to life. - Agnes Martin

Bad artists copy. Good artists steal. - Pablo Picasso

Blessed are they who see beautiful things in humble places where other people see nothing. - Camille Pissarro

Bring your humanity to your art. Bring your art to humanity. - Maxime Lagac

Creativity is allowing yourself to make mistakes. Art is knowing which ones to keep. - Scott Adams

Do not be afraid of being wrong; just be afraid of being uninteresting. - T. Carl Whitmer

Do not fear mistakes. There are none. - Miles Davis

Enlightenment is the journey back from the head to the heart. - Pandit Ravi Shankar

Every artist dips his brush in his own soul, and paints his own nature into his pictures. - Henry Ward Beecher

Every artist was first an amateur. - Ralph Waldo Emerson

Every child is an artist. The problem is how to remain an artist once we grow up. - Pablo Picasso

Everything alters me, but nothing changes me. - Salvador Dal

Everything you can imagine is real. - Pablo Picasso

Finish the work, otherwise an unfinished work will finish you. - Amit Kalantri

Great art picks up where nature ends. - Marc Chagall

Have no fear of perfection, youll never reach it. - Salvador Dal

I dream of painting and then I paint my dream. - Vincent Van Gogh

I paint and sculpt with the blues. - John Hammond

I shut my eyes in order to see. - Paul Gauguin

I would like to paint the way a bird sings. - Claude Monet

I would rather die of passion than of boredom. - Emile Zola

If I could say it in words there would be no reason to paint. - Edward Hopper

If music is a place - then jazz is the city, folk is the wilderness, rock is the road, classical is a temple. - Vera Nazarian

If you dont make mistakes, you arent really trying. - Coleman Hawkins

It is better to fail in originality than to succeed in imitation. - Herman Melville

Its not what you look at that matters, its what you see. - Henry David Thoreau

Life is a lot like jazz, its best when you improvise. - George Gershwin

Life doesn't imitate art, it imitates bad television. - Woody Allen

Life is like a trumpet - if you don't put anything into it, you don't get anything out of it. - William Christopher Handy

No great artist ever sees things as they really are. If he did, he would cease to be an artist. - Oscar Wilde

No great work of art is ever finished. - Michelangelo

One persons craziness is another persons reality. - Tim Burton

Painting is easy when you dont know how, but very difficult when you do. - Edgar Degas

Painting is just another way of keeping a diary. - Pablo Picasso

Painting is silent poetry. - Plutarch

Perspective is to painting what the bridle is to the horse, the rudder to a ship. - Leonardo da Vinci

Talking about music is like dancing about architecture. - Thelonious Monk

The aim of art is to represent not the outward appearance of things, but their inward significance.- Aristotle

The artist must train not only his eye but also his soul. - Wassily Kandinsky

The artist sees what others only catch a glimpse of. - Leonardo da Vinci

The arts are not a way to make a living. They are a very human way of making life more bearable. - Kurt Vonnegut

The earth has music for those who listen. - William Shakespeare

The essence of all beautiful art, all great art, is gratitude. - Friedrich Nietzsche

The function of the artist in a disturbed society is to give awareness of the universe, to ask the right questions, and to elevate the mind. - Marina Abramovic

The great artist is the simplifier. - Vincent Van Gogh

The greatest works of art speak to us without knowing us. - Alain de Botton

The job of the artist is always to deepen the mystery. - Francis Bacon

The most beautiful experience we can have is the mysterious - the fundamental emotion which stands at the cradle of true art and true science. - Albert Einstein

The most creative people are willing to work in the shadow of uncertainty. - Ed Catmull

The purpose of art is washing the dust of daily life off our souls. - Pablo Picasso

The true use of art is, first, to cultivate the artists own spiritual nature. - George Inness

The world always seems brighter when youve just made something that wasnt there before. - Neil Gaiman

There are always flowers for those who want to see them. - Henri Matisse

There are no rules. That is how art is born, how breakthroughs happen. Go against the rules or ignore the rules. That is what invention is about. - Helen Frankenthaler

There are paintings that take on a life of their own, and do not allow you to finish them. - Efrat Cybulkiewicz

To be an artist is to believe in life. - Henry Moore

To be great, art has to point somewhere. - Anne Lamott

To create, one must first question everything. - Eileen Gray

To draw you must close your eyes and sing. - Pablo Picasso

What art offers is space - a certain breathing room for the spirit. - John Updike

When Im playing, Im never through. Its unfinished. I like to find a place to leave for someone else to finish it. Thats where the high comes in. - Miles Davis

When love and skill work together, expect a masterpiece. - John Ruskin

When people believe in boundaries, they become part of them. - Don Cherry

See the original post:

Art in times of coronavirus 100 inspiring quotes on World Art Day 2020 - YourStory

Coronavirus outbreak brings into focus elements of blind faith, bigotry in society and the need to… – Firstpost

Joining the Dotsis a weekly column by author and journalist Samrat in which he connects events to ideas, often through analysis, but occasionally through satire

***

The coronavirus pandemic was bad enough. It is being worsened by the unchecked rise of other viruses that existed long before the novel coronavirus disease struck the viruses of blind faith and its companion, bigotry. The immediate provocation for some of the bigotry currently on view in India is over the role of a religious gathering organised by a Muslim group, the Tablighi Jamaat, which contributed significantly to the spread of the coronavirus in this country. The Union health ministry has reported that the Tablighi gathering in Delhis Nizamuddin held in March resulted in 1,023 COVID-19 positive cases in 17 states, accounting for 30 percent of total cases in the country as of 4 April.

India is not the only country where the Tablighis held that gathering. Similar events took place in Pakistan and Malaysia, with similar results. There was a big Tablighi gathering in Lahore attended by more than 1,00,000 people which has left that countrys authorities scrambling to isolate and quarantine the attendees. More than 20,000 people who attended the event had been quarantined by Monday, with the Pakistan government looking for the rest. In Malaysia, the Tablighi gathering resulted in hundreds of cases and spread the disease to neighbouring countries. Reuters reported the countrys health minister saying on 17 March that of Malaysias 673 confirmed cases at the time, nearly two-thirds were linked to the four-day Tablighi meet.

The Tablighis were not the only religious sect that put faith over reason. South Korea faced the same problem of a religious gathering leading to the disease numbers exploding. There, the group responsible was the Shincheonji Church of Jesus, which at one point accounted for half of all cases in South Korea. That was in early March, before the World Health Organisation declared it a pandemic. However, the global spread since then, and the rising number of deaths, has still not convinced Christian evangelicals in America that there is such a thing as a coronavirus threat. Influential evangelical preachers have been calling on followers to attend church gatherings and dismissing concerns over the need for social distancing. One of them, Rodney Howard-Browne, was finally arrested last week for continuing to host large church services despite government orders to residents to stay home.

In India, apart from the Tablighis, there was a case of a man, Baldev Singh, in Punjab, who attended a large Sikh religious gathering called Hola Mohalla before dying of coronavirus disease. After that, around 40,000 people in Punjab had to be quarantined. In Kerala, police arrested 28 people including temple trust office-bearers after a crowd of Hindus gathered for the Arattu procession at the Malayinkeezhu Sree Krishnaswami Temple in Thiruvananthapuram. Both these events took place in March, with the Kerala event coming after the WHO had warned that the world was facing a global pandemic.

A volunteer sprays disinfectant on a masked man as he leaves the Nizamuddin area, where several people showed symptoms of infection from coronavirus after taking part in a religious gathering. PTI

Organisers of all these events, of different faiths from different corners of the earth, chose to go ahead with holding large gatherings at a time when the world was already grappling with the spread of the coronavirus. The people who got sick after contracting the disease at some of these gatherings in various countries are the believers who attended the gatherings. By putting faith over reason, they endangered themselves, their near and dear ones, and their societies and countries. Everyone, most of all those who have been infected, is now paying the price for that.

The tendency of religious people to put their trust in blind faith over reason is a liability even in normal times. It leads to ridiculous and often unintentionally funny statements and actions, such as those relating to the magical powers of cow urine or the sexual habits of peacocks here in India. However, it also creates more serious issues, for instance relating to contraception and abortion in Catholic countries, or female genital mutilation in certain Muslim communities.

Apart from issues within communities, the tribalism and irrationality of religion also lead to often-violent tensions between communities. Yet, it is possible that these very characteristics and the related congregational nature of religious practice that is impelling people of varied faiths to risk their lives by defying social distancing orders around the world may be foundational to the idea of religion, and perhaps to human civilisation itself.

Intriguing hints of such a possibility exist in a place called Gobekli Tepe in southern Turkey, not far from that countrys border with Syria, where massive stone pillars carved with figures of animals have stood for around 11,600 years. They were built seven millennia before the pyramids, and are more than twice as old as the Indus Valley site of Mohenjo Daro. They date from before the invention of agriculture. Klaus Schmidt, the German archaeologist who led excavations at the site, suspected that the social organisation required to build them may have led to not just agriculture but to civilisation itself. His view on this, and the story of Gobekli Tepe, can be found in a wonderful report in the June 2011 issue of National Geographic magazine on The Birth of Religion.

The spiritual, philosophical, mystical and even revelatory aspects of modern religions are however far removed from such social, congregational roots. Interestingly, those other aspects are the ones that led to the birth of several of the currently dominant faiths. Social distancing of a sort was of critical importance in their genesis.

Buddhism emerged from belief in the enlightenment achieved by the Buddha through his practice of solitary and silent meditation for 49 days. Islam was born from the revelations believed to have been received by the Prophet Muhammad when he was alone in a mountaintop cave near Mecca. A critical event in Judaism and Christianity was the moment when Moses, in solitude, is believed to have received the ten commandments on Mount Sinai. Hinduism is replete with stories of sages meditating in their retreats, or on remote mountaintops, for years.

The supernatural is obviously a very big part of most of those stories. It is possible that they serve a deep need of the human psyche.

The hunger for the supernatural may come as Ramayana and Mahabharata or as Harry Potter and the X-Men. It is unreasonable and probably undesirable to expect that belief in magic will vanish from the minds of humans. However, it is reasonable to hope that even those who believe in the supernatural will respect the natural, heed the scientific consensus on social distancing, and shun congregational gatherings.

Nothing prevents anyone from meditating in whatever solitude and silence they are able to find in their homes under lockdown in this pandemic-afflicted world. There is nothing whatsoever that prevents anyone of any faith from reading the Upanishads, Bible, Quran or Guru Granth Sahib. No virus is stopping anyone anywhere from spiritual practice or study. In other words, there need not be any conflict between the advice of science and needs of faith.Blind faith, tribalism and bigotry are no longer necessary aspects of religious or spiritual practice.

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

Go here to read the rest:

Coronavirus outbreak brings into focus elements of blind faith, bigotry in society and the need to... - Firstpost

How to Use Hemp Oil for Maximum Benefits?

Hemp oil just like add medicine is known for its therapeutic effects for the human body. You may not find any formal research about it but can find several anecdotes that can help to validate this stance.

Many people often confuse hemp oil with marijuana because both the plants belong to the same Cannabis Sativa plant family but the major difference between both is the difference in the amount of THC (tetrahydrocannabinol) in them. Marijuana has a very high amount of THC which makes it a ‘drug for recreational purposes’ while, hemp oil has only 0.3% of THC. However, both of them can be used for treating people with a psychological disorder, such as medical marijuana anxiety treatment is being used widely and is found to be effective too just as hemp oil usage.

Why hemp oil is beneficial

You might be wondering why hemp oil is beneficial for the human body or why is it found to be effective. The reason is that our body has an Endocannabinoid System (ECS) i.e. it has a series of receptors that can be found throughout our body. These receptors are highly responsive to cannabinoid intakes such as hemp oil, thus helps in making it effective for the human body. Hemp oil is found to be effective for:

  • Boosting up Metabolism
  • Digestive System
  • Immune System
  • Regulating Sleep Cycle
  • Mood and Anxiety
  • Neuro Protection
  • Skin Disorders

There are many ways in which hemp oil can be used effectively. Here is how to use hemp oil so that its benefits can be maximized:

Applying Hemp Oil Topically:

Hemp oil is widely known for its pain-relieving qualities, particularly for arthritis patients. Moreover, it is found to be effective for controlling acne. Applying the hemp oil directly on the affected area is highly beneficial. For example, if you have pain in your joints, apply hemp oil on that area and it will work like a charm and your pain will fizzle away.

Oral Consumptions:

Hemp oil has different oral applications based upon the purpose of its usage or choice of the consumer. For example, it can be used as a tincture, a liquid that can be taken sublingually (under the tongue) using a dropper to monetarize the dosage. Certain flavors can be added to the hemp oil. Such as coconut oil or grapeseed oil to make its taste more palatable.

Secondly, the pure extract of hemp oil can be taken as well. Pure extracts are much thicker and unflavored and can be taken using the oral syringe. Thirdly, hemp oil can be taken in the form of edibles such as chews, chocolates or lozenges. People won't even know that they are taking the supplements. We can pick from whatever suits them the best just as we can pick our favorite candy out of so many.

Capsules are one of the easiest ways to take the hemp oil orally. They can be easily swallowed and won’t seem like an extra burden to you as we take other supplements regularly. Capsules are made with the pure extract of hemp oil, but you must make sure to buy them from an authorized dealer to be assured of the authenticity of the product.

Oral consumption of hemp oil is highly recommended to improve your digestive system and boost up immunity. The effective methods of hemp oil usage differ with its purpose of usage.

What is the preferred dosage of hemp oil consumption?

You must not tr hemp oil on your own if you want to use it for purposes. Other than skin disorders. You must consult your doctor about it because he/she can guide you as per your medical history. The medicines that you might already be taking.

Hemp oil is found to have more benefits than side effects, which makes it worth trying it. Do give it a try as per your doctor’s guidance!

 

 

Why Clovis Oncology, Immunomedics, and Puma Biotechnology All Spiked Today – Motley Fool

What happened

Healthcare stocks, on balance, had a great start to the week today. Cancer companies in particular posted strong gains almost across the board Monday. For instance, the stock ofClovis Oncology(NASDAQ:CLVS)ended the day up by 15.2%, shares of Immunomedics (NASDAQ:IMMU) hit a high of 10.2% before ultimately closing up by 8.5%, and Puma Biotechnology(NASDAQ:PBYI)printed a 16.3% gain today.

The odd part to this rising-tide phenomenon is that none of these companies issued a single press release or market-moving Securities and Exchange Commission filing Monday. Instead, this sea of green appears to be the result of institutional investors fleeing weaker parts of the market like oil in favor of safe havens like healthcare. Cancer stocks, after all, should be essentially immune to the economic impacts of the COVID-19 pandemic, given that most patients can't skip out on lifesaving treatments.

Image Source: Getty Images.

If this flight-to-safety thesis is true, then Clovis, Immunomedics, and Puma would arguably all make outstanding vehicles to gain exposure to the high-growth oncology space. Each of these stocks is grossly undervalued relative to its long-term value proposition. Wall Street's 12-month price targets on these names underscore this point nicely. Even after today's sizable moves, for instance, Clovis, Immunomedics, and Puma are still trading well below their 12-month price targets.

Why are these three cancer stocks undervalued right now? Clovis and Puma have both struggled to gain the confidence of investors in this volatile market due to the uncertain commercial outlook for their flagship cancer meds. Immunomedics, on the other hand, scored a major late-stage trial win with itstriple-negative breast cancer drug candidate sacituzumab govitecan earlier this year. Even so, the company's stock has yet to truly price in the full value of this positive clinical outcome, presumably because of the unfavorable market conditions in general.

Are these suddenly red-hot biotech stocks still worth buying? In a word, yes. Clovis should grab an important label expansion for its ovarian cancer med Rubraca later this year, a pivotal event that has the potential to be an inflection point for the company's commercial operations.

Puma, on the other hand, still looks like a decent buy based on the long-term commercial prospects of its breast cancer med Nerlynx. The drug's sales have been slowed down by its onerous side-effect profile, but it should nevertheless still achieve at least $300 million in annual sales. Puma's market cap, by contrast, is only $440 million at the time of this writing.

And Immunomedics stands out as a fantastic buyout target. Triple negative breast cancer is a high-value indication for which few drugs have panned out in clinical studies. Immunomedics, in turn, should fetch a healthy tender offer if sacituzumab govitecan does indeed get the green light from regulators.

More:
Why Clovis Oncology, Immunomedics, and Puma Biotechnology All Spiked Today - Motley Fool

Does Apex Biotechnology Corp.s (TPE:1733) 20% Earnings Growth Make It An Outperformer? – Simply Wall St

Measuring Apex Biotechnology Corp.s (TSEC:1733) track record of past performance is an insightful exercise for investors. It enables us to reflect on whether the company has met or exceed expectations, which is a powerful signal for future performance. Below, I will assess 1733s recent performance announced on 31 December 2019 and compare these figures to its historical trend and industry movements.

Check out our latest analysis for Apex Biotechnology

1733s trailing twelve-month earnings (from 31 December 2019) of NT$114m has jumped 20% compared to the previous year.

Furthermore, this one-year growth rate has exceeded its 5-year annual growth average of -28%, indicating the rate at which 1733 is growing has accelerated. Whats enabled this growth? Lets take a look at if it is merely due to industry tailwinds, or if Apex Biotechnology has experienced some company-specific growth.

In terms of returns from investment, Apex Biotechnology has fallen short of achieving a 20% return on equity (ROE), recording 6.7% instead. Furthermore, its return on assets (ROA) of 4.3% is below the TW Medical Equipment industry of 6.2%, indicating Apex Biotechnologys are utilized less efficiently. And finally, its return on capital (ROC), which also accounts for Apex Biotechnologys debt level, has declined over the past 3 years from 12% to 9.3%. This correlates with an increase in debt holding, with debt-to-equity ratio rising from 21% to 29% over the past 5 years.

Apex Biotechnologys track record can be a valuable insight into its earnings performance, but it certainly doesnt tell the whole story. Recent positive growth isnt always indicative of a continued optimistic outlook. There may be factors that are impacting the industry as a whole, thus the high industry growth rate over the same time period. You should continue to research Apex Biotechnology to get a better picture of the stock by looking at:

NB: Figures in this article are calculated using data from the trailing twelve months from 31 December 2019. This may not be consistent with full year annual report figures.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

More:
Does Apex Biotechnology Corp.s (TPE:1733) 20% Earnings Growth Make It An Outperformer? - Simply Wall St

Nanoparticles in Biotechnology and Pharmaceuticals Market 2020 Break Down by Top Companies, Applications, Challenges, Opportunities and Forecast 2026 …

Shire

Nanoparticles in Biotechnology and Pharmaceuticals Market: Competitive Landscape

The last chapter of the Nanoparticles in Biotechnology and Pharmaceuticals market research report focuses exclusively on the competitive landscape. It examines the main market players. In addition to a brief overview of the business, analysts provide information on their assessment and development. The list of important products in preparation is also mentioned. The competitive landscape is analyzed by understanding the companies strategies and the initiatives they have taken in recent years to overcome intense competition.

Nanoparticles in Biotechnology and Pharmaceuticals Market: Drivers and Restraints

The report explains the drivers of the future of the Nanoparticles in Biotechnology and Pharmaceuticals market. It assesses the different forces which should have a positive impact on the whole market. Analysts have looked at investments in research and development for products and technologies, which should give players a significant boost. In addition, the researchers undertook an analysis of the evolution of consumer behavior which should have an impact on the cycles of supply and demand in the Nanoparticles in Biotechnology and Pharmaceuticals market. In this research report, changes in per capita income, improvement in the economic situation and emerging trends were examined.

The research report also explains the potential restrictions on the Nanoparticles in Biotechnology and Pharmaceuticals market. The aspects assessed are likely to hamper market growth in the near future. In addition to this assessment, it offers a list of opportunities that could prove lucrative for the entire market. Analysts offer solutions to turn threats and restrictions into successful opportunities in the years to come.

Nanoparticles in Biotechnology and Pharmaceuticals Market: Regional Segmentation

In the following chapters, analysts have examined the regional segments of the Nanoparticles in Biotechnology and Pharmaceuticals market. This gives readers a deeper insight into the global market and allows for a closer look at the elements that could determine its evolution. Countless regional aspects, such as the effects of culture, environment and government policies, which affect regional markets are highlighted.

Ask for Discount @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=19246&utm_source=COD&utm_medium=007

What will the report contain?

Market Dynamics: The report contains important information on influencing factors, market drivers, challenges, opportunities and market trends as part of the market dynamics.

Global Market Forecast: Readers receive production and sales forecasts for the Nanoparticles in Biotechnology and Pharmaceuticals market, production and consumption forecasts for regional markets, production, sales and price forecasts for the Nanoparticles in Biotechnology and Pharmaceuticals market by type and consumption forecasts for the Nanoparticles in Biotechnology and Pharmaceuticals market per application.

Regional Market Analysis: It can be divided into two different sections: one for the analysis of regional production and one for the analysis of regional consumption. Here, analysts share gross margin, prices, sales, production, CAGR, and other factors that indicate the growth of all regional markets examined in the report.

Market Competition: In this section, the report provides information on the situation and trends of competition, including mergers and acquisitions and expansion, the market shares of the three or five main players and the concentration of the market. Readers could also get the production, revenue, and average price shares of manufacturers.

Key Players: The report provides company profiles for a decent number of leading players in the Nanoparticles in Biotechnology and Pharmaceuticals market. It shows your current and future market growth taking into account price, gross margin, income, production, service areas, production locations and other factors.

Complete Report is Available @ https://www.verifiedmarketresearch.com/product/Nanoparticles-in-Biotechnology-and-Pharmaceuticals-Market/?utm_source=COD&utm_medium=007

We also offer customization on reports based on specific client requirement:

1- Free country level analysis for any 5 countries of your choice.

2- Free Competitive analysis of any market players.

3- Free 40 analyst hours to cover any other data points

About us:

Verified market research partners with the customer and offer an insight into strategic and growth analyzes, Data necessary to achieve corporate goals and objectives. Our core values are trust, integrity and authenticity for our customers.

Analysts with a high level of expertise in data collection and governance use industrial techniques to collect and analyze data in all phases. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research reports.

Contact us:

Mr. Edwyne FernandesCall: +1 (650) 781 4080Email: [emailprotected]

Get Our Trending Report

https://www.marketresearchblogs.com/stem-cell-alopecia-treatment-market-size-growth-analysis-opportunities-business-outlook-and-forecast-to-2026/

Tags: Nanoparticles in Biotechnology and Pharmaceuticals Market Size, Nanoparticles in Biotechnology and Pharmaceuticals Market Trends, Nanoparticles in Biotechnology and Pharmaceuticals Market Forecast, Nanoparticles in Biotechnology and Pharmaceuticals Market Growth, Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis

Here is the original post:
Nanoparticles in Biotechnology and Pharmaceuticals Market 2020 Break Down by Top Companies, Applications, Challenges, Opportunities and Forecast 2026 ...

Biotechnology Faculty Lecturer Joins the BPPT Covid-19 Task Force – QS WOW News

The Atma Jaya Catholic University of Indonesia (AJCUI) is contributing to reducing the Covid-19 pandemic in Indonesia. Lecturer in the Faculty of Biotechnology and Senior Researcher at BPPT, Dr. Irvan Faizal, M.Eng., has joined the TFRIC19, as the Secretary of the Task Force and the Coordinator of the Non-PCR Rapid Diagnostic Test Sub-Task Force. Lecturer of Faculty of Engineering, Dr. Ir. Lukas, MAI, CISA, IPM., is also in the task force to offer his expertise in the field of Artificial Intelligence.

The Sub-Task Force, in which Dr. Irvan is the coordinator-of, will produce a Rapid Diagnostic Test for COVID 19. In collaboration with BPPT, ITB, UNPAD, UGM, and the Research and Development Department from the Ministry of Health Research, the Rapid Diagnostic Test design for antibody detection (IgG / IgM).

I partook in the team for the reason that the competencies and abilities, especially in research and innovation, I possess, might be utilized to play a role in the handling and detecting the COVID-19 in Indonesia, said Dr. Irvan.

The lecturer in the Faculty of Biotechnology also explained that in the produced of the antibodies detection, it was designed using the COVID-19 virus from Indonesian virus isolates, hence it would be more sensitive and specific for Indonesias characteristics.

Furthermore, this sub-task force will also produce detection products using a microchip that can detect antigens so that they can be used to identify virus infections after two days of infected a person.

This innovative product may be utilized to detect COVID-19 in a patient under close monitoring (PDP) and patient under observation (ODP) in the short of time (10-15 minutes). This product expected to be more sensitive and specific for Indonesians patience in comparison to imported IgG / IgM detection, which generates low-value sensitivity and specificity, explained Dr. Irvan.

As is known, BPPT has five quick mitigation plans for the COVID-19 outbreaks. These include Whole Genome COVID-19 Origin Indonesia(analysis and forming using data from infected Indonesians),Non-PCR Diagnostic Test COVID-19 (development in the form of dip-sticks and micro-chips), andPCR Diagnostic Test COVID-19 (development following the latest mutations of COVID-19).

The other plans areCOVID-19 Pandemic Facilities and Infrastructure(strengthening suggestions and detection targets, mobile labs, health logistics, and innovation ecosystems), andArtificial Intelligence COVID-19(information technology and AI application to support diagnose and decision making).

Dr. Irvan hopes to keep supporting all teams that have performed sustained and zealously against COVID-19 in creating products that are useful in preventing, detecting, and responding to COVID-19. He advised that the community always maintain health and continue to pray.

Please support every stakeholder who had a significant concern in developing an innovative product and in research to prevent, detect, and respond to the pandemic. Take care of your health, physical distance, and keep praying, he said.

Continue reading here:
Biotechnology Faculty Lecturer Joins the BPPT Covid-19 Task Force - QS WOW News

Providence-based EpiVax collaborates on ongoing research for a COVID-19 vaccine – The Brown Daily Herald

As COVID-19 continues to spread throughout the country and the world, EpiVax, a biotechnology company based in Providence, is currently leading collaborative efforts to design a vaccine against the virus.

EpiVax has been dedicated to applying (their) tools to re-engineering therapeutic proteins and to designing new vaccines, according to their website. They are partnering with researchers from four organizations to work on the COVID-19 vaccine: Generex Biotechnology, the University of Georgia, Immunomic Therapeutics and an organization based in Belgium. Other researchers have reached out to the company to aid in collaborative efforts as well.

Bringing Potential Benefits

The candidate vaccines being developed by EpiVax are T-cell-based. Unlike other COVID-19 vaccines in the works that are B-cell-based, the T-cell vaccines do not stimulate antibodies, which are molecules created by the immune system to protect against infection. Some studies have proposed that in the case of COVID-19, antibody stimulation may exacerbate respiratory symptoms, said Katie Porter, EpiVaxs business development manager.

From studies on other coronaviruses, we have learned that often the antibodies are not long-lived, so they do not hold up their defense against invading viruses for extended periods of time as the virus evolves, said Lalit Beura, assistant professor of molecular microbiology and immunology, whose research involves T-cells. Having another arm of the immune system in the form of a T-cell-focused vaccine is helpful.

EpiVax: Starting with Sequencing

There are people who are concerned that were working with the actual virus in Providence, but that is not the case, Porter said. Rather, EpiVax is using a digital representation. After determining the viruss genome, the researchers selected the amino acid sequences that form the COVID-19 SARS-CoV-2 proteins that T-cells recognize and used a computer-based technology they developed to determine the regions of these proteins that instigate the greatest immune system response. The researchers will use these short protein segments to design vaccine candidates.

EpiVax has created three designs for the collaborators to use for their distinct, biological methods of delivering the vaccine. These designs include a set of distinct, short peptides, a string of connected peptides and a modified protein. Peptides are composed of the same molecules as proteins but are shorter. We are working with various collaborators on a daily basis to provide them with the best design options for their platform technology, Porter said. For instance, the Generex collaborators are using a set of peptides while the University of Georgia collaborators will be using the modified protein model consisting of the full viral protein.

While each of these organizations is working on their own projects, they all share a common goal of developing a vaccine. EpiVax has begun delivering its protein designs to its collaborators and optimizing the strains for their mechanism. For the company, sharing their sequencing and initial design work with collaborators who can help create an eventual vaccine is important because we have the ink, and we need to give it to someone with the pen so that together we can write, Porter said.

University of Georgia: Modifying the Protein Model

Ted Ross, director of the Center for Vaccines and Immunology, Georgia Research Alliance Eminent Scholar and professor of infectious diseases at the University of Georgia, and two other investigators at the university will engineer the modified protein sequences that EpiVax is designing. Then they will run trials in animal models mice and ferrets by infecting them with the altered peptides to determine whether they produce a better immune response than the wild type viruss proteins do. If this is the case, the researchers plan to expose these animals to SARS-CoV-2 to ensure that this potential vaccination is effective. The groups expectation is to have this data ready by the middle of this summer.

Ross and his group have also been working on developing a universal flu vaccine, a vaccine that could potentially be used for all influenza viruses without requiring constant changes. Perhaps we could use those (same) techniques to eventually create a universal coronavirus vaccine, Ross said.

Generex Biotechnology: Modifying the Peptide Model

Generex Biotechnology, another therapeutics company, is modifying the peptides provided by EpiVax. They are first synthesizing the peptides predicted by EpiVaxs analysis using their Ii-Key technology. An li-Key facilitates the attachment of a four-amino-acid-long peptide to a part of the COVID-19 virus. This technology serves as a sort of flag on the virus, providing a way to artificially activate the T-cells more quickly than would happen in a typical immune response.

The researchers plan on conducting their studies by testing the modified peptides, determined by EpiVax and optimized by Generex, using blood cells from COVID-19-recovered patients. They hope to complete these studies in three to four months prior to testing the potential vaccine in live animals and people.

It is a two-fold process, said Eric von Hofe, chief scientific officer of NuGenerex Immuno-Oncology, a subsidiary of Generex. The team will be looking for a T-cell response to these peptides, as well as the generation of antibodies. After starting and completing trials in animal models, Generex hopes to begin clinical trials with about 200 volunteers that will receive the peptide-based vaccine to determine whether this produces the desired immune response and to ensure the safety of the vaccine.

The biggest advantage is that peptides represent the minimal unit required to produce an immune response while reducing safety concerns associated with other proposed COVID-19 vaccines that are RNA- and DNA-based and have the potential to insert into a persons DNA, von Hofe said. But none of these types of vaccines have been approved yet for the treatment of infectious diseases, he added.

Fundamentals of Funding

Despite the preliminary successes the companies have seen thus far, funding remains a critical part of the picture. Funding often pushes back the timeline, or worse, cancels hopes of a trial continuing. EpiVaxs and Generexs earlier research on vaccine candidates for the H1N1 and SARS pandemics were halted largely due to funding limitations.

Still, the companies believe that this time around, it will not be as much of a barrier. If our trials are successful, Im sure that there will be opportunities to take a vaccine candidate even further, Porter said. There is government and other funding available, but there are many people trying to get it. We have many collaborations in place to move a COVID vaccine forward, so chances for success are very good.

Von Hofe highlighted the importance of reaching out to government officials, as well as voting for political candidates who will support vaccine research. Public interest is acute in the midst of a pandemic and then fades away, von Hofe said. But with the last 20 years having brought a handful of pandemics, now it is pretty clear that the regular emergence of pandemic or potentially pandemic viruses will not be going away, he added. Whatever happens with COVID-19, we will have learned a lot that will be applicable to whatever potential pandemic may come next; it is clear that we need to be better prepared.

While the timeline for this COVID-19 vaccines development remains indefinite, according to EpiVaxs website, were in the race to have the vaccines in clinical trials by the fall, Porter said.

See the original post:
Providence-based EpiVax collaborates on ongoing research for a COVID-19 vaccine - The Brown Daily Herald

Puma Biotechnology Inc. [PBYI] Analyzing the PBYI using Fundamentals and Trend Analysis – The Dwinnex

Puma Biotechnology Inc. [NASDAQ: PBYI] shares went higher by 12.21% from its previous closing of 8.60, now trading at the price of $9.65, also adding 1.05 points. Is PBYI stock a buy or should you stay away?

The stock had a rather active trading session with the latest closing, by far recording 1.09 million contracts. Compared to the average trading volume of PBYI shares, the company saw a far better performance. Moreover, the stock has a 34.74M float and a 20.78% run over in the last seven days. PBYI share price has been hovering between 35.27 and 5.50 lately, and is definitely worthy of attention.

Professional stock traders oftentimes make sure they verify what some leading Wall Street voices have to say about a potential buy. Currently, in relation to Puma Biotechnology Inc. [PBYI], the latest Wall Street average recommendation we can view is from the fiscal quarter that will be ending in the month of 12/30/2019. On average, stock market experts give PBYI an Hold rating. The average 12-month price forecast for this stock is $9.65, with the high estimate being $15.00, the low estimate being $6.00 and the median estimate amounting to $13.50. This is compared to its latest closing price of $8.60.

Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for Puma Biotechnology Inc. [PBYI] is sitting at 3.00. This is compared to 1 month ago, when its average rating was 3.00.

Keep on the lookout for this organizations next scheduled financial results, which are expected to be made public on 05/06/2020.

Now lets turn to look at profitability: with a current Operating Margin for Puma Biotechnology Inc. [PBYI] sitting at -23.30% and its Gross Margin at 86.50%, this companys Net Margin is now -27.80. These metrics indicate that this company is not generating as much profit, after accounting for expenses, compared to its market peers.

This companys Return on Total Capital is -24.14, and its Return on Invested Capital has reached -47.06. Its Return on Equity is -302.70%, and its Return on Assets is -29.10%. These metrics suggest that this Puma Biotechnology Inc. does a poor job of managing its assets, and likely wont be able to provide successful business outcomes for its investors in the near term.

Turning to investigate this organizations capital structure, Puma Biotechnology Inc. [PBYI] has generated a Total Debt to Total Equity ratio of 688.48. Similarly, its Total Debt to Total Capital is 87.32, while its Total Debt to Total Assets stands at 51.18. Looking toward the future, this publicly-traded companys Long-Term Debt to Equity is 673.45, and its Long-Term Debt to Total Capital is 85.41.

What about valuation? This companys Enterprise Value to EBITDA is -9.35. The Enterprise Value to Sales for this firm is now 1.07, and its Total Debt to Enterprise Value stands at 0.35. Puma Biotechnology Inc. [PBYI] has a Price to Book Ratio of 19.64, a Price to Cash Flow Ratio of 15.16.

Puma Biotechnology Inc. [PBYI] has 38.22M shares outstanding, amounting to a total market cap of 368.82M. Its stock price has been found in the range of 5.50 to 35.27. At its current price, it has moved down by -72.64% from its 52-week high, and it has moved up 75.45% from its 52-week low.

This stocks Beta value is currently 1.21, which indicates that it is 9.49% more volatile that the wider market. This stocks Relative Strength Index (RSI) is at 56.30. This RSI score is good, suggesting this stock is neither overbought or oversold.

Shares of Puma Biotechnology Inc. [PBYI], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this companys financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.

Read the original:
Puma Biotechnology Inc. [PBYI] Analyzing the PBYI using Fundamentals and Trend Analysis - The Dwinnex

Global Nanotechnology in Drug Delivery Market 2020 by Manufacturers, Countries, Type and Application, Forecast to 2026 – NJ MMA News

Developed after comprehensive analysis, a new research report titled Global Nanotechnology in Drug Delivery Market 2020 by Manufacturers, Countries, Type and Application, Forecast to 2026, covers significant market factors such as market size, market trends, market opportunities, and market challenges. The report gives important figures on the market status of producers and offers useful advice and direction for businesses and individuals interested in the global Nanotechnology in Drug Delivery industry. The report comprises vital data like compounded annual growth rate, working capital, enterprise value & value of leading industry players. The research provides leading growth status, including developments, segmentation, landscape analysis, product types, and applications.

Report Enfolds:

The report sheds light on statistical features involving demand and supply, cost arrangement, barriers and provocations, product type, main market players, technology, regions, and applications. The report estimates the global Nanotechnology in Drug Delivery market size and future development prospects of this market depending on varied segments like type, application, and region. Data charts and figures based on types and applications are also provided in this report. The research study has the potential to impact its peers and parent market as the growth rate of the market is being accelerated by increasing product demand, growing disposable incomes, innovative products, raw material affluence, and changing consumption technologies.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/23803

Some of key competitors or manufacturers included in this report are: Access Pharmaceuticals, Alkermes, Aquanova, Camurus, Capsulution Pharma, Celgene,

The report provides a detailed breakdown of the market region-wise and categorizes it at various levels. Regional segment analysis displaying regional production volume, consumption volume, revenue, and growth rate from 2020-2026 covers: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa). All regions are analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the market.

On the basis of product, the study gives the production capacity, gross revenue, cost analysis, the market share and CAGR for each type categorized as: Targeted Delivery, Drug Package

On the basis of the applications, the global Nanotechnology in Drug Delivery market report involves the significant applications of the sector by examining the current market scenario, industry overview, and rate of consumption to give the market share and CAGR for each application, including: Cancer, Tumor, Other,

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/23803/global-nanotechnology-in-drug-delivery-market-2020-by-manufacturers-countries-type-and-application-forecast-to-2026

Furthermore, the report segmentation of the global Nanotechnology in Drug Delivery market by various relevant criteria is elaborated upon in the report. Here each segment is examined in terms of historical performance and in terms of growth potential to provide a detailed analytical view of the market. The research study gives exact subtleties to the assessment of the competition, especially based on regional perception and future forecasts. The analysis helps to identify drivers, restraints, weaknesses, opportunities, and threats.

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team (sales@marketsandresearch.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

See the rest here:
Global Nanotechnology in Drug Delivery Market 2020 by Manufacturers, Countries, Type and Application, Forecast to 2026 - NJ MMA News

Nanotechnology and Nanomaterials Market Structure, Industry Inspection, and For – News by aeresearch

The recent report on Nanotechnology and Nanomaterials market thoroughly analyzes the industry sphere with key emphasis on consumption and production. With respect to consumption, the report entails details about volume share and valuation, while deciphering the price trends over the forecast period. Information regarding import and export patterns across various geographies is provided in the report.

The Latest Research Report on Nanotechnology and Nanomaterials Market size | Industry Segment by Applications (Aerospace,Automotive,Medical,Military,Electronics andOthers), by Type (Carbon?Nanotubes,Nanoclays,Nanofibers,Nanosilver andOthers), Regional Outlook, Market Demand, Latest Trends, Nanotechnology and Nanomaterials Industry Share, Research Growth Forecast & Revenue by Manufacturers, The Leading Company Profiles, Growth Forecasts 2026.

Request Sample Copy of this Report @ https://www.aeresearch.net/request-sample/161759

Speaking of production, the study discusses the manufacturing of product, raw material procurement cost, and profit margins amassed by the key Nanotechnology and Nanomaterials market players, along with variations in unit cost offered by these manufacturers in several regions. More importantly, the report encompasses a detailed projection about the consumption and production patterns displayed by the Nanotechnology and Nanomaterials market in the upcoming years.

A summary of regional outlook:

An overview of the product spectrum:

A brief summary of application topography:

An insight into the competitive terrain:

To conclude, the report analyzes the Nanotechnology and Nanomaterials market by multiple categorizations to offer concise information about the industry including the downstream buyers, upstream raw materials, and distribution channels. Details regarding market challenges, along with global trends, drivers and growth prospects that will influence market growth are stated, to facilitate the shareholders to gain deeper understanding the Nanotechnology and Nanomaterials market.

Objectives of the Global Nanotechnology and Nanomaterials Industry Research Report: Forecast to 2026:

Request Customization on This Report @ https://www.aeresearch.net/request-for-customization/161759

Here is the original post:
Nanotechnology and Nanomaterials Market Structure, Industry Inspection, and For - News by aeresearch

Weekly Update: Global Coronavirus Impact and Implications on Nanotechnology in Medical Devices Market Outlook 2020: Business overview, Industry…

The report on the Nanotechnology in Medical Devices market provides a birds eye view of the current proceeding within the Nanotechnology in Medical Devices market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Nanotechnology in Medical Devices market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Nanotechnology in Medical Devices market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

Nanotechnology in Medical Devices market reports deliver insight and expert analysis into key consumer trends and behaviour in marketplace, in addition to an overview of the market data and key brands. Nanotechnology in Medical Devices market reports provides all data with easily digestible information to guide every businessmans future innovation and move business forward.

Request Sample Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2531168&source=atm

The worldwide Nanotechnology in Medical Devices market is an enlarging field for top market players,

The following manufacturers are covered:3MDentsply InternationalMitsui ChemicalsStrykerAAP ImplantateAffymetrixPerkinelmerST. Jude MedicalSmith & NephewStarkey Hearing Technologies

Segment by RegionsNorth AmericaEuropeChinaJapanSoutheast AsiaIndia

Segment by TypeBiochipImplant MaterialsMedical TextilesWound DressingCardiac Rhythm Management DevicesHearing Aid

Segment by ApplicationTherapeuticDiagnosticResearch

Make An EnquiryAbout This Report @ https://www.researchmoz.com/enquiry.php?type=E&repid=2531168&source=atm

This Nanotechnology in Medical Devices report begins with a basic overview of the market. The analysis highlights the opportunity and Nanotechnology in Medical Devices industry trends that are impacted the market that is global. Players around various regions and analysis of each industry dimensions are covered under this report. The analysis also contains a crucial Nanotechnology in Medical Devices insight regarding the things which are driving and affecting the earnings of the market. The Nanotechnology in Medical Devices report comprises sections together side landscape which clarifies actions such as venture and acquisitions and mergers.

The Report offers SWOT examination and venture return investigation, and other aspects such as the principle locale, economic situations with benefit, generation, request, limit, supply, and market development rate and figure.

Quantifiable data:-

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America, Europe, China, Japan, Southeast Asia, India

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2531168&licType=S&source=atm

Research objectives and Reason to procure this report:-

Finally, the global Nanotechnology in Medical Devices market provides a total research decision and also sector feasibility of investment in new projects will be assessed. Nanotechnology in Medical Devices industry is a source of means and guidance for organizations and individuals interested in their market earnings.

See the original post:
Weekly Update: Global Coronavirus Impact and Implications on Nanotechnology in Medical Devices Market Outlook 2020: Business overview, Industry...

Outlook into the Worldwide Electron Microscopes Industry to 2025 – Featuring Nikon Metrology, ZEISS Germany & Thermo Fischer Scientific Among…

DUBLIN--(BUSINESS WIRE)--The "Global Electron Microscopes Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering.

The global electron microscopes market is witnessing a healthy growth due to the requirement of advanced and magnified image output of objects up to several nanometers. In comparison to the optical microscope, an electron microscope generates much magnified and detailed output. An electron microscope uses an electron-optical lens that helps in generating a magnified image of an object up to 10,000,000x on a shorter wavelength.

A major application of an electron microscope is to gather information about microorganisms, cells, biopsy samples, etc. Its application in the healthcare industry has boosted the market. An electron microscope is used in other appliances such as for material research, data storage, and Biology & life Science.

Companies Mentioned

Market Drivers

Electron Microscope market is driven by its ability to showcase higher and refining images, to magnify an object to several nanometers. It has also helped in increasing the demand for nanotechnology. Semiconductors also use an electron microscope for inspection of small size semiconductors like wafers. In the field of circuit edit and analyzing circuit failure. The electron microscope is used in the polymer industry, agriculture, nanotechnology, and atomic studies.

The integration of advanced display modalities like high definition and 3-Dimensional will increase the demand for an electron microscope market. Growing applications in life sciences and chemistry will boost the electron microscope market. A microscope can be also used for the characterization of materials, to study their internal structures and for other related applications.

By Geography

Regionally the electron microscopes market is classified into North America, South America, Europe, Middle East, and Africa, and the Asia Pacific The report also analyses major countries across these regions with complete analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers. Developing countries to see substantial growth due to the rise in the medical tourism industry and developing healthcare infrastructure. Increasing research and development in an electron microscope will further increase its demand in developing countries.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

4.1. Market Drivers

4.2. Market Restraints

4.3. Porters Five Forces Analysis

4.4. Industry Value Chain Analysis

5. Global Electron Microscopes Market Analysis, by Product Type

5.1. Introduction

5.2. Scanning Electron Microscope

5.3. Transmission Electron Microscope

5.4. Reflection Electron Microscope

6. Global Electron Microscopes Market Analysis, by Application

6.1. Introduction

6.2. Material Sciences

6.3. Lifesciences

6.4. Nanotechnology

7. Global Electron Microscopes Market Analysis, by Geography

7.1. Introduction

7.2. North America

7.2.1. USA

7.2.2. Canada

7.2.3. Mexico

7.3. South America

7.3.1. Brazil

7.3.2. Argentina

7.3.3. Others

7.4. Europe

7.4.1. Germany

7.4.2. France

7.4.3. United Kingdom

7.4.4. Spain

7.4.5. Others

7.5. Middle East and Africa

7.5.1. Saudi Arabia

7.5.2. Israel

7.5.3. UAE

7.5.4. Others

7.6. Asia Pacific

7.6.1. China

7.6.2. Japan

7.6.3. South Korea

7.6.4. India

7.6.5. Others

8. Competitive Environment and Analysis

8.1. Major Players and Strategy Analysis

8.2. Emerging Players and Market Lucrativeness

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Vendor Competitiveness Matrix

9. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/x3ab6z

Read more:
Outlook into the Worldwide Electron Microscopes Industry to 2025 - Featuring Nikon Metrology, ZEISS Germany & Thermo Fischer Scientific Among...

Anatomy of misgovernance – The News International

As flies to wanton boys are we to gods/ They kill us for their sport -Thomas Hardy

The crisis of governance that afflicts Pakistan is multi-dimensional; its causes are many and deep-seated; and it pervades all aspects of national life.

Having identified the main symptoms and dimensions of this crisis in my last article (March 28), it would be pertinent to probe its underlying causes and structural underpinnings. Although there may be sector-specific problems, this article seeks to focus on some of the generic issues that lie at the root of the problem.

Political uncertainty and turbulence have plagued Pakistan since its inception. Fortified with the vision and ideals of the Quaid-e-Azam in the early years, the new-born country was able to tide over its teething problems despite the cynical indifference of the departing colonial rulers and sinister hostility of its irredentist neighbour. However, since the untimely demise of its founding father, the country has been oscillating between democratic and authoritarian forms of government and helplessly groping for a stable, progressive and truly representative polity.

Poor quality of political leadership, coupled with self-serving machinations of the establishment, have prevented genuine democracy from striking deep roots in the country, while the midwifery of state organs to promote vested rather than public interest has undermined the rule of law and good governance.

At the heart of the crisis of governance lies a polarised polity, marked by vertical cleavages between the rich and the poor, the privileged and the underprivileged, the dominant elites and the faceless masses on the one hand, and horizontal divisions along ethnic, tribal, sectarian, and political lines on the other. The stratified structure of society, together with the failure of state institutions to enforce rule of law, has obstructed the social and economic development of the country.

The social and state structure in the country, modelled on the colonial pattern of master and subject, has not changed even after independence. The relationship between the ruler and the ruled assumes different forms in political, social, economic and administrative settings but remains unchanged in its essence and substance. The wielders of power in different spheres compete with one another for parochial gain but are united in the furtherance of common class interests. Barring a few exceptions, political, social and economic power remains vested in closely-knit personal and family networks, to the utter exclusion of the silent, suffering majority of people.

The force of public opinion, on the other hand, remains weak, fragile and unsure of itself. It is not so well articulated through mechanisms within the general public to be able to exert pressure on the multiple and mutually reinforcing centres of power and restrain them from sacrificing public good at the altar of personal or class interest. The self-styled leaders of public opinion have developed their own class interests on the periphery of the centres of power and act as safety valves for letting off steam rather than serving as catalysts for mobilising the people.

The civil society itself is marred by lack of awareness of common goals and collective action. There is a great proclivity towards individualistic pursuits and self-interest. The social fabric is riven with ethnic, sectarian and social cleavages. As a result, people are not able to coalesce for the pursuit of common objectives. The civil society could rightly be described as a sack of potatoes. The thwarted awareness of civic rights and responsibilities among the populace lies at the root of the malaise.

That is what keeps rule of law from striking deep roots into the soil of this country. That is what makes it an empty slogan rather than a real, vibrant force protecting people against the depredations of power. That is what encourages the strong and discourages the weak; that is what makes the rich richer and the poor poorer; that is what leads to the abuse of women and children; that is what makes the plunder of national resources possible.

Rule of law is more honoured in the breach than in the observance. In the first place, there is no dearth of laws that are discriminatory in nature and have been framed over the years to promote and protect the vested interests. Numerous laws have been enacted to serve immediate and short-term objectives and without due deliberation. The speed and gusto with which we framed some laws of the land must have made Lord Macaulay revolve in his grave with an awful sense of irony.

Second, the enforcement of laws has also been scandalously weak, partisan and discriminatory. Those who can buy off or pressurise law enforcers slip through the net. The reach of the long arm of law does not go beyond the weak and the underprivileged. Those trapped in legal processes slug through inordinate delays in disposal of cases and are forced to pander to the insatiable avarice of the custodians of the law.

Last but not the least, rampant corruption and favouritism have crowded out merit and competitiveness in all matters concerning government dispensation, be it recruitment or promotions, award of contracts or economic incentives, disposal of state land or public procurement. A culture of nepotism has become the order of the day and the concept of merit-based competition a cry in the wilderness.

The author is a former cabinet secretary.

Email: [emailprotected]

Originally posted here:
Anatomy of misgovernance - The News International

The Anatomy of a Pandemic – tntribune.com

NASHVILLE, TN We were warned but stuck our heads in the sand and didnt see the pandemic coming. Suddenly we found ourselves at war against an invisible enemy. The first casualty was the truth.

It will all be over by Easter. We have plenty of PPEs. African Americans are immune. The virus only hits old people. It wont tank the economy. And so on.

The amount of bull thats been shoveled for public consumption is greater the higher up the chain of command you go. Nobody can beat the President for tripe and outright chicanery. Governor Bill Lee followed close behind, apparently believing what Washington was telling him and by telling us the feds were going to provide enough medical supplies to handle the crisis if we needed them. We needed them and they didnt supply them. They didnt have any.

Then there was Mayor Cooper who told reporters that we had plenty of resources to beat the virus. And the ever-optimistic Dr. Alex Jahangir, who, after being asked several times How many test kits do you have? eventually evinced that he was happy about the number. It took him three weeks to get happy.

The lack of candor from official sources has created a credibility gap on top of a public health crisis. Officials seem to be doing better lately with the truth. Now they are telling us social distancing has flattened the infection curve, so maybe there is reason for optimism.

Should we believe them? There are two competing models out there, one by Vanderbilt University epidemiologists and another by University of Washington researchers at theInstitute for Health Metrics and Evaluation(IHME), a global health research center.

Both models used the same data from Wuhan, China, where the pandemic began, and both say it will last much longer if social distancing is stopped too soon. But they differ by several weeks when they predict the peak will be reached in Tennessee. One says we will reach the peak in April; the other says May or even June.

A Vanderbilt University Health Policy expert told the Tribune that the two teams made some different assumptions when they constructed their models. The IHME model predicted an earlier peak by assuming Tennessee would keep the number of deaths low as doctors in China did in Wuhan. The Vanderbilt team assumed Tennessee would have a comparable number of hospitalized patients to Wuhan.

But by grafting the Wuhan experience onto Tennessee, the IHME model essentially makes an even more optimistic assumption than our optimistic scenarioand thus arrives at that peak earlier, said Dr. John Graves, Professor of Health Policy at Vanderbilt University.

Bad or incomplete data are two reasons why scientific predictions can be quite different. With COVID-19 it comes back to the lack of test kits. The way scientists accurately predict the spread of disease is by looking for it randomly in a population. If you only test sick people, as we did in the U.S. because we didnt have enough tests, you wont get an accurate picture. And most importantly, you wont get a handle on the number of asymptomatic carriers of the virus who can spread it but do not show symptoms.

So without good data, health policies like quarantines and stay-at-home orders are responding blindly and are likely to be ineffective or at the very least inefficient. Resources can be placed where they are most needed if you know where the disease is spreading fastest.

So, widespread testing as well as social distancing, isolation, and quarantine should be part and parcel of a good public health response to an epidemic like COVID-19.We did not do that in the U.S. and now we have more COVID-19 victims than any other country in the world.

As of April 18, 6,762 have tested positive, 719 people in Tennessee have been hospitalized with the disease, and 145 people have died. Graves and his colleagues say lifting restrictions too soon would keep doubling serious cases every few days until by mid-May 50,000 people would need to be hospitalized.

Only a fraction of the people who have been infected have been tested, said Graves. He said a sustained drop in cases is necessary before social distancing should be relaxed. The model that his Vanderbilt colleagues created for COVID-19 is specific to Tennessee.

We have to think about this like a multi-stage relay race where social distancing can begin to pass off to the next leg of the relay and that means reliable and speedy testing and contact tracing. Absent that we risk have an epidemic surge out of control once again, he said.

Health authorities are talking about testing more widely but the medical protocol to only test symptomatic patients is still in place throughout Davidson County and throughout most of the country. The risk of a worsening epidemic will continue until we find out exactly who is positive. Without knowing that all-important information, any prediction about when the peak has been reached or if we can go back to work, or whether the epidemic will return later is impossible to know for sure.

Vanderbilt researchers recently updated their model and it shows the virus slowing down in some regions but not in others.

Governor Lee is talking about slowly opening up the state to get the economy running again. We will address these issues in an upcoming article. Stay tuned to the next chapter in the COVID-19 story.

See the original post here:
The Anatomy of a Pandemic - tntribune.com

3D anatomy tables to boost UMPI-UMFK nursing program – The County

ALL-UMFKUMPInursing-31-19

Nursing student Sam Carpenter takes the blood pressure of fellow student Sarah Sutherland on Sept. 11, 2018, in the nursing lab at the University of Maine at Presque Isle. UMPI and the University of Maine at Fort Kent collaborate to offer UMFK's nursing program to students at the Presque Isle campus.(Staff photo/Anthony Brino)

Nursing student Sam Carpenter takes the blood pressure of fellow student Sarah Sutherland on Sept. 11, 2018, in the nursing lab at the University of Maine at Presque Isle. UMPI and the University of Maine at Fort Kent collaborate to offer UMFK's nursing program to students at the Presque Isle campus.(Staff photo/Anthony Brino)

Students in the University of Maine at Fort Kent nursing program, both on the Fort Kent campus and at the University of Maine at Presque Isle, will have a high-tech new way to learn about human anatomy when classes resume after the COVID-19 state of emergency.

PRESQUE ISLE, Maine Students in the University of Maine at Fort Kent nursing program, both on the Fort Kent campus and at the University of Maine at Presque Isle, will have a high-tech new way to learn about human anatomy when classes resume after the COVID-19 state of emergency.

The universities have acquired two state-of-the art Anatomage tables. These tables, used by the worlds top medical schools and hospitals and featured by TEDTalks and PBS, are described as the most technologically advanced 3D visualization systems for anatomy and physiology education.

We are pleased to have such a powerful teaching tool available for our professors and students, said Erin Soucy, UMFK dean of undergraduate nursing. Rather than seeing a picture in a textbook, students see a realistic, 3-D picture of body systems, organs, and even cells. Learning is an interactive process and students remember more when they can link content to a visual image.

UMFKs bachelor of science in nursing program, which is also delivered on the UMPI campus, offers nursing classes, labs, and clinicals and strives to deliver as many hands-on and high-tech activities as possiblefrom mock hospital suites filled with equipment theyll see in a real hospital setting to human patient simulator mannequins.

The program delivered at UMPI is designed to meet the needs of place-bound students those who arent able to travel to Fort Kent to complete the BSN degree due to family and work responsibilities as well as to address nursing workforce challenges.

UMPI President Ray Rice said, This will give students an absolute advantage in terms of understanding anatomy and body systems and being able to apply that knowledge once they are in the career field.

The highly interactive tables features a life-sized display, touch-screen technology and 3D imagery, allowing users to view photorealistic anatomical structures layer by layer and from every angle. These structures are based on thousands of real human cases that have been digitized in the highest possible resolution.

Both tables have arrived at their respective campuses and the nursing faculty are preparing them for use in class.

Having access to this state-of-the-art medical technology has a profound impact on nursing students, as well as students enrolled in all UMFK/UMPI programs, said Stacy Thibodeau, UMFK assistant professor of nursing who delivers classes at UMPI. The incorporation of the Anatomage Table into our lectures and labs allows for a virtual learning experience of tomorrow, to be experienced in todays UMFK/UMPI classroom. This is an exceptional learning and diagnostic resource that is FDA approved.

For information about the UMFK BSN program, call 207-834-7600 or email umfklife@maine.edu. To learn more about the program delivered on the UMPI campus, call 207-768-9532 or email umpi-admissions@maine.edu.

Submitted by the Community and Media Relations Office of the University of Maine at Presque Isle.

Thank you for reading your 4 free articles this month. To continue reading, and support local, rural journalism, please subscribe.

Continued here:
3D anatomy tables to boost UMPI-UMFK nursing program - The County

Breaking down the anatomy of a fantasy football dynasty trade | PFN – Pro Football Network

-This past week, in one of Pro Football Networks dynasty fantasy football leagues, a trade went down that caused quite the controversy. League members and website lead editors, Ryan Gosling and Corey Ashburn, decided to move two young quarterbacks in a 12-team, Superflex, full point PPR league. The trade included a number of pieces but focused around Dak Prescott and Carson Wentz. Was it a fair trade? Can you compare an emphasis on value to the confidence of a teams offense?

By breaking down the anatomy of the trade, we get a better understanding of the mindset of both owners involved. Can fandom doom a fantasy team? Or is value overrated? These are questions that this trade tries to answer, while we open the discussion to fellow fantasy football enthusiasts. Who won this trade? Well, only time will tell. But lets break down why both owners are pumping their chests in victory.

Before we can break down the trade, it is important to add context. Merely mentioning the players does not give you, the reader, enough information to decide if this move made sense. In this specific league, our rosters consist of the following:

1QB, 1SF, 2RBs, 2WRs, 1TE, 2Flex with 21 bench spots for a total of a 30-man roster.

Both Ryan and Corey were quite active throughout the draft process, with Ashburn implementing an interesting trade back theory. Ryan traded up to get his guy as a strategy.

Dak Prescott, Matthew Stafford, Jameis Winston, and Jacoby Brissett

I am a bit worried about my QB depth. If Winston doesnt land a starting spot somewhere this offseason, I could be looking at only two usable QBs this year. I do not like to feel this uncomfortable in a Superflex league.

My running back room is bad. I plan on using my rookie draft capital to correct this, but for now, Im staring at the worst RB group in the league.

Similar to the RBs, my WR depth is not good enough. I love my top four, but if one of them goes down to injury, I will struggle in my flex position. The 2020 WR class is loaded with depth, and I plan on using some draft capital to help this as well.

Looking up and down my roster, there isnt one position that I am worried about. I feel like I have good depth in general, but could use a bonified starting tight end, especially considering this league has a premium at the position.

My wide receiver class is quite young, but they each have a high upside. However, they are all facing some questions marks at the QB position. Will Joe Burrow develop a connection with Boyd, or will he prefer Green? What about Curtis Samuel and his new QB Teddy Bridgewater? Calvin Ridley and Tyler Lockett are both starting caliber, but behind them, there is a concern.

Also, having traded away my first-round rookie pick in this years draft to move up, I dont have any capital to add to my team. My first selection isnt until the beginning of the second round, and there could be a lack of starting-caliber rookies at that point. As some in the sports world would say, I cornered myself into a win now mode.

My top two QBs rival any other group in the league. I love Daks durability, weapons, and rushing ability. Stafford was having a career year before his back injury last season, and I think he can be a top-10 QB for another three to five years if he stays healthy.

My RB1 and starting WRs are awesome. I am high on Sanders this year and landed his handcuff in Boston Scott, so I feel secure with one starting RB spot. My group of Godwin, Allen, Beckham Jr., and Gallup is the best four-some in the league.

My draft capital is what the kids like to call fire. I believe I will be able to land two of the top-three stud RBs in this class at 1.04 and 1.06. Then, I should be able to pick BPA with my three second-round picks.

Before the trade, I liked both my quarterback and running back situations. At QB, I have Matt Ryan, who is as solid as they come, and Carson Wentz. Wentz, although very injury prone, could be a top-10 fantasy weapon if the team decides to give him some weapons. Ryan plays on a team with a terrible defense and could have to air it out often. Pairing him with Calvin Ridley set em up for success.

When looking at my RBs, I have two of the remaining workhorse backs in the league. With so many running back by committees in the NFL, securing both Barkley and Fournette pretty much guarantees production.

Behind my starters, I have two other backs who could be starters next season. Jordan Howard currently has very little competition in Miamis backfield and will likely be paired up with one of the more promising backs coming out of the draft. I still think he has promise and could be a good dump-off option for Fitzpatrick. Henderson is going to be competing for touched with Malcolm Brown in L.A., but I believe he has the talent to become the lead guy.

Continue to the next page to see how the trade process went down.

Continue reading here:
Breaking down the anatomy of a fantasy football dynasty trade | PFN - Pro Football Network

The detailed anatomy of the S&p 500 upswing – FXStreet

Todays extensive article will evaluate the week that just passed, and examine the health of the S&P 500 advance. Well look both at various credit market metrics, and at the key S&P 500 sectors and ratios. Putting the pieces of the puzzle together will enable us to make profitable trading decisions as the bullish fever is rising. Just how much is that sentiment justified?

Lets start with the S&P 500 itself, and check the weekly and daily perspectives (charts courtesy of http://stockcharts.com).

The weekly chart shows how far the rally has reached. The breakdown below the red support zone marking the Dec 2018 lows has been invalidated, and the subsequent bears push lower has failed. Last two weeks brought us higher prices, but the upside momentum decreased in last week as the bears reemerged.

Were the volume behind the upswing larger, it would make the price recovery more credible. Its true that the weekly indicators are by and large on their buy signals, but how much can they be trusted?

Lets check the detailed daily chart to find out.

Fridays session opened with a bullish gap well above the 50% Fibonacci retracement, and while the sellers took price action back to its proximity, the buyers staged a strong comeback in the sessions final hour. Failing that, many of the below bullish-leaning points couldnt have been made.

Encouragingly, it happened on higher volume than what characterized the last two down days. While the volume was slightly higher than that of Tuesdays push higher, it was lower than last Fridays one (that was the day when the 50% Fibonacci retracement was first tested). This raises some doubts about the bulls ability to extend their gains considerably higher in the coming days.

The daily indicators are getting increasingly extended, with both CCI and RSI struggling to keep from rolling over. Stochastics overbought readings will arguably take longer than it is the case with CCI to flash its upcoming sell signal. These increase the likelihood of the S&P 500 taking a breather shortly.

Just like weve seen quite a few bullish gaps in the recent days and early April, bears may respond with some of their own making (and today may be first such day as the S&P 500 futures trade at around 2825 as we speak). Remember, many of those declining days in March were characterized by sudden bursts of buying within the final hour this pattern is not exclusive to the up days since the Mar 23 low.

Not only have prices reached the 50-day moving average thats serving as resistance, but also the lower border of the sizable early March bearish gap, which is reinforced by the 61.8% Fibonacci retracement at its upper end.

As we move to the credit markets assessment, lets bring up our Thursdays intraday commentary as it remains valid also today and given the S&P 500 closing prices, even more so:

() the credit market metric of high yield corporate bonds to short-term Treasuries keeps trading down. That serves to confirm thin air as the S&P 500 challenges 2800, and actually points to a disconnect between the two markets. And its the bond guys who usually get it right, which is one more reason apart from the fundamental coronavirus fallout, why we expect renewed selling in stocks.

So, what about corporate bonds to Treasuries? While the investment-grade corporate bonds (LQD ETF) keep trading in a tight range much closer to their recent highs than the high-yield ones (HYG ETF), its the riskier ones that should be leading higher in a risk-on rally. Otherwise, it would represent flight to quality along the lines of Treasuries outperformance (SHY and IEI ETFs). In other words, we would still be in a risk-off environment.

The ratio of corporate junk bonds to short-term Treasuries didnt start leading higher on Friday either. Its still trading well below the Fed $2.3T bombshell highs, pointing to the defensive nature of the S&P 500 rally.

Talking short-dated Treasuries, lets see with what kind of veracity they moved lower as the S&P 500 moved above the 50% Fibonacci retracement.

Thats not what we would call a turning point or downside break exactly. Such action supports the notion of risk aversion.

Examination of the S&P 500 performance by various key sectors and their ratios should help us refine the picture.

Well start with the leading metric of risk-taking: the ratio of financials to utilities.

As the ratio appears ready to beat late-March lows and take on the March panic bottom next, it shows that financials as the risk-on asset class are declining relative to the defensive utilities sector.

Are utilities (XLU ETF) really as strong here just as Treasuries would imply? What are the other bright spots in the S&P 500 rally? And what about financials (XLF ETF)? Lets check all three.

Utilities are clearly among the best-performing S&P 500 sectors. As theyre consolidating their post-Fed announcement gains, they havent performed as well as the short-term Treasuries (SHY ETF) or investment-grade corporate bonds (LQD ETF), but still have outperformed the credit markets (HYG and HYD ETFs).

Healthcare is a star performer among the S&P 500 sectors, closing higher than any day in March. While the daily indicators are extended, the volume doesnt warn of an impending reversal.

Having repelled the selling pressure to close the opening gap (just like S&P 500) in the final hour of trading, technology shares are another sector leading the S&P 500 higher. Apart from the extended daily indicators, the key watchout is the volume thats trending down since the second half of March. This shows that the bulls arent as strong as they appear to be. Remember, tops form when theres no one left to buy. Just how close are we to this point?

Financials are clearly lagging behind. Similarly to the leaves that fall off a tree one-by-one as autumn progresses, a stock market rally stalls and rolls over as more and more sectors refuse to move higher. In other words, a rising number of troops dont follow the generals uphill.

Even if the S&P 500 rally goes on a bit longer in the short-term, this constellation doesnt bode well for its prospects. Neither does the weak performance of the energy sector shown below.

Theyre the laggards, and over at Oil Trading Alerts, were making a killing shorting oil as you can see in its most recent Alert. Such a weak performance is a bad omen for stocks, despite the low weight of the energy sector in the index.

Kicking off with the financials-to-utilities ratio, weve have already covered the three top-share S&P 500 sectors (technology, healthcare and financials). But there is one more highly informative ratio to look at. Its the consumer discretionaries to consumer staples.

The caption says it all. The ratio isnt yet trending up, and reveals the badly-shaken consumer. It reflects the stunning drop of Wednesdays retail sales data (changed consumer attitudes and outlook), and doesnt really point to its turnaround in May. Thats similar to what we see in the financial sector banks are raising the loan losses provisions as the pain is slowly but surely cascading through the system. The current earnings projections are also overly optimistic, which goes to show that should stocks keep trading at these levels, theyll become relatively more expensive than in the recent past as the P/E ratio would show. Coming back to the discretionaries to staples, it shows no return of the consumer just yet and highlights caution.

Its totally appropriate to quote our Fridays lengthy analysis:

() how come stocks are showing such strength amid the divergencies and faced with grim fundamental data?

Just as weve seen late last week flattening of the coronavirus curve in some of the hotspots such as NYC, yesterdays unemployment claims (as unprecedented as the figure is) have come below the 6000K+ mark of two prior weeks. Is it a satisfactory flattening of the labor market curve? The bleeding is there,
sizable and without an end in sight really. More layoffs are coming as the cascading through the real economy proceeds. Even the Feds Beige Book dating to April 15 is saying so.

Talking flattening of the coronavirus curve, the news on the ground doesnt fully support the optimism. Tuesday and Wednesday brought us the record number of coronavirus casualties, with 2,364 and 2,371 dead respectively. If thats the new normal, it shows that weve reached no US-wide plateau yet, despite the lockdown in hardest-hit NYC going into effect on Mar 22. Thats quite a few weeks already and thats the case for the overwhelming majority of other states too.

In fact, the lockdown contribution to halting the exponential spread might be exaggerated, as Mark Twain would himself say regarding reports of his death. Take a look at the comparisons to Sweden, where no lockdown has been instituted, and the country remains open for business. The country is faring reasonably well on a per capita basis.

Trump understands the need to reopen the economy, and has earlier in March called for it to happen by Easter. While that hasnt been the case, the idea has gained traction also within Democratic strongholds on the East and West Coasts. While the governors may disagree on timing, theyre moving in the same direction.

This brings us to the catalyst of yesterdays aftermarket upswing in the S&P 500. It has been known already on Wednesday that the President plans to unveil federal guidelines to reopen America for business. And the moment of glory came late yesterday Eastern Time.

But where is the beef, as the memorable Wendys ad says?

The offered guidelines are about letting some US states and employers to do away with most social distancing measures within several weeks. Discussing preconditions and stages of relaxation, the document is exactly what its called a guideline. In other words, its a federal outline.

Please remember that its the States Governors that are responsible for the action on the ground. All the lockdowns have been initiated by Governors, and sometimes even Mayors. None originated at the federal level. While the Trump guidelines are sending an important message, its impact lies in the PR arena as it steals the spotlight while nothing groundbreaking has just yet happened statewide.

While the S&P 500 futures like it and are clinging to most of the overnight gains (trading around 2865 currently), its far from a safe bet that the courage to start returning life to normal wont backfire, and that the US wont experience another sharp increase in new infections. Look no further than to Singapore for a second wave of the outbreak. The situation in Spain is again worsening after allowing the estimated 300K workers to resume their roles.

Coming back to the Opening Up America Again guidelines, do they mean that the consumer is coming back in a big way?

Were doubtful, and had this to say about the recovery prospects:

() In short, the V-shaped recovery is a fantasy. Weve discussed the disruptions in our Sundays special Stock Trading Alert, and encourage you to read it if you hadnt done so already.

Take a look at China overnight, theyve reported the quarterly GDP figures. The drop of -6.8% is unprecedented, and their fixed asset investment and retail sales still keep falling like a hard rock on a year-on-year basis. We fully expect a similar dynamic to play out in the US as well.

These points remain valid, and weve seen resurgence of cases in Japan as the Land of the Rising Sun declares national emergency and the UK extends lockdown for at least another three weeks. Meanwhile in the US, ramped up coronavirus testing on a per capita basis would sharpen the picture

Many governors seek more test kits and testing so as to move forward with reopening the economies. Getting past the peak doesn't mean that new infections and deaths would plummet to zero just like that. The public is waking up to the economic damage, and weve seen certain protests already. These go to show that the return to status quo ante will be a long process where pressing a button doesnt translate into the economy springing back to life overnight. Its not only in the US the uncertainties regarding reopening for business persist globally.

Were in the earnings season, with heavy reporting and guidance this week, and even more so the coming one. Markets optimistic assessment will meet the on-the-ground reality of dealing with the economic disruptions, apart from the expect bunch of incoming data.

Still within Fridays Alert, we went on to explore the weekly and daily message copper is sending. The metal with PhD. in economics closed up on the day, supporting the S&P 500 upswing. While extended, the red metal can still move higher in the short run. But is it out of the woods, pointing to a continuing recovery in the S&P 500?

Lets check another metric of the risk-on/risk-off the copper to gold ratio.

While the ratio gapped higher and can clearly add to its gains in the short-term, it just illustrates the deep fall off the cliff, supporting the conclusion that stocks are still far from sounding the all-clear.

Q: I am reading about trouble in the European Bond market (negative rates have destroyed it), and the possible imposition of a digital currency there. Germany and the Netherlands might be forced to shoulder the debt. Do you follow this and factor it in in some way? Along with this is the Repo market and the Feds juggling act to balance it. So there are many macro-economic forces at play here.

A: The coronavirus crisis is putting strains on the European debt market, and Italian debt market is actually among the biggest ones in the world. The rise in Italian yields brings back the memories of PIIGS crisis with the familiar fault line between the Club Med countries and the richer North. Weve seen it in the failed coronabonds negotiations. Were certainly paying attention also to the gentle nudges towards cashless society these are all being discounted in the market action on an ongoing basis. Similarly to the Repo crisis and pre-corona strains in some of the incoming US data, there are many moving parts in this saga. As the market decides what to listen to and how to interpret it, you can count on us to bring the truly breaking news and their impact to your attention.

Q: it would be helpful to discuss the impending impact of financial crises.

A: As there are parallels between the 2008 and current situation, lets take a look at the Great Recession and stock market performance back then. There have been many false dawns and great volatility, especially in the months of October and November. In the Hope and Change sentiment of the day, stocks scored many sharp rallies in the short run as bad economic news kept coming in. But early in March 2009, theyve stopped reacting to poor data that kept pouring in long after the March 09 bottom.

And we expect it to be the case regarding the coronavirus crisis as well. Again, the stock market will reach the bottom earlier than the real economy does. Leaving aside the question whether we have reached the bottom on March 23 or not (we actually might), the risk of a downswing remains high. Markets dont just come off all-time highs without developing some kind of a trading range next.

Summing up, the S&P 500 added to opening gaps gains in the final hour of trading, which certainly helped in brightening the short-term outlook for the bulls. The breakout above the 50% Fibonacci retracement stands a chance as the 50-day moving average and the lower border of the sizable early March bearish gap (reinforced by the 61.8% Fibonacci retracement at its upper end) are being tested. As the credit markets continue to underperform, the S&P 500 rally is being led by defensive sectors and technology. The financials-to-utilities and discretionaries-to-staples ratios dont paint a picture of lasting price recovery. Neither does the copper-to-gold ratio. While we expect stocks to roll over to the downside as the coronavirus fallout gets worse bef
ore getting better, that neednt happen tomorrow or the day after. The drive to reopen the economy may come back to bite the decision-makers as the flattened coronavirus curve still appears elusive. Sideways trading followed by renewed selling pressure taking on the March lows, is the optimistic scenario here.

Want free follow-ups to the above article and details not available to 99%+ investors? Sign up to our free newsletter today!

Read the original post:
The detailed anatomy of the S&p 500 upswing - FXStreet

Wild Turkey Anatomy and Physiology – OutdoorHub

Turkeys are always a challenge to hunt, but their anatomy and physiology is just as intriguing. Some think they are ugly, while others appreciate the array of colors and behavior. Heck, they were almost our national bird. So, as you gear up to chase these illusive birds in their natural habitat, take some time to familiarize yourself with some basic wild turkey anatomy and physiology.

The head of a turkey is a colorful cornucopia. Composed of the caruncles, wattles, snood and dewlap, all are used for different purposes. The changing of color and shape in males emanates aggression, sexual arousal and overall mood. It is a signpost for other turkeys. There are also tiny hairs and feathers around the ear to aid in hearing.

The main fighting tool of a tom is the spur. Since they do all the fighting for the right to breed, they are only present in males. Gobblers jump and use their spurs as daggers to attempt to injure the competition. Spur length is good teller of age, too. Toms with spurs longer than an inch are mature birds, while toms with spurs an inch or less are usually two-year old birds.

A turkeys beard is made from the same material as a rhinoceros hornkeratin. Keratinized epithelial cells are cells filled with the protein keratin. In this case, feathers in toms (and in some hens) keratinize and form the beard. So, a beard is essentially a collection of specialized feathers.

Archibald Rutledge once said, the turkeys eyes are such that he can see a bumblebee turn a somersault on the verge of the horizon. Turkeys can see as a human would while using 8-10x zoom on a pair of binoculars. They also do not have to focus in on objects. If they can see it, it is always in focus. Being able to see in a 300-degree range helps, too. The only spot they cannot see without turning their heads is directly behind them.

Oh, and unlike deer they can see color very well. Good luck.

A turkeys breast is what we call white meat, while its thighs and legs are dark meat. Why is this? White meat is made of light muscle. These muscles are meant for short burst of energy and lack a lot of hemoglobin to sustain activity for too long. Dark meat is composed of dark muscle, which contains high levels of hemoglobin and help sustain a lot of activity for long periods of time. Turkeys walk way more than they fly, so that is why the meat of the legs is dark and the breast is white. (This is why the breast of migratory birds like ducks is dark, FYI).

What interesting things have you noticed about a turkeys anatomy and physiology?

See original here:
Wild Turkey Anatomy and Physiology - OutdoorHub